Buscador de publicaciones

Publicaciones

  • Martínez-Bonet M, Puertas MC, Fortuny-Guasch C, Ouchi D, Mellado J, Rojo P, Noguera-Julián A, Muñoz-Fernández MA and Martinez-Picado J.

    Establishment and Replenishment of the Viral Reservoir in Perinatally HIV-1-infected Children Initiating Very Early Antiretroviral Therapy

    CLINICAL INFECTIOUS DISEASES . 61(7): 1169-1178. Nº de citas: 97

    [doi:10.1093/cid/civ456]

  • Sollai S, Noguera-Julián A, Galli L, Fortuny-Guasch C, Deyà-Martinez A, de Martino M and Chiappini E.

    Strategies for the Prevention of Mother to Child Transmission in Western Countries An Update

    PEDIATRIC INFECTIOUS DISEASE JOURNAL . 34(5): 14-30. Nº de citas: 7

    [doi:10.1097/INF.0000000000000661]

  • Fortuny-Guasch C, Deyà Á, Chiappini E, Galli L, De Martino M and Noguera-Julián A.

    Metabolic and Renal Adverse Effects of Antiretroviral Therapy in HIV-infected Children and Adolescents

    PEDIATRIC INFECTIOUS DISEASE JOURNAL . 34(5): 36-43. Nº de citas: 43

    [doi:10.1097/INF.0000000000000663]

  • Falcon-Neyra L, Benmarzouk-Hidalgo OJ, Madrid L, Noguera-Julián A, Fortuny-Guasch C, Neth O and López-Cortés L.

    No Differences of Immune Activation and Microbial Translocation Among HIV-infected Children Receiving Combined Antiretroviral Therapy or Protease Inhibitor Monotherapy

    Medicine . 94(11): . Nº de citas: 4

    [doi:10.1097/MD.0000000000000521]

  • Noyola DE, Alarcon A, Noguera-Julián A, Muntasell A, Munoz-Almagro C, García J, Mur A, Fortuny-Guasch C and López-Botet M.

    Dynamics of the NK-cell subset redistribution induced by cytomegalovirus infection in preterm infants

    HUMAN IMMUNOLOGY . 76(2-3): 118-123. Nº de citas: 17

    [doi:10.1016/j.humimm.2015.01.017]

  • Morén C, Noguera-Julián A, Garrabou G, Rovira N, Catalán M, Bañó M, Guitart-Mampel M, Tobías E, Hernández S, Cardellach F, Miró O and Fortuny-Guasch C.

    Mitochondrial disturbances in HIV pregnancies

    Aids . 29(1): 5-12. Nº de citas: 23

    [doi:10.1097/QAD.0000000000000486]

  • Tudor-Williams G, Cahn P, Chokephaibulkit K, Fourie J, Karatzios C, Dincq S, Opsomer M, Kakuda TN, Nijs S, Tambuyzer L, Tomaka FL and PIANO study group.

    Etravirine in treatment-experienced, HIV-1-infected children and; adolescents: 48-week safety, efficacy and resistance analysis of the; phase II PIANO study

    HIV MEDICINE . 15(9): 513-524. Nº de citas: 17

    [doi:10.1111/hiv.12141]

  • Deyà-Martinez A, Noguera-Julián A, Vila J, Vila A, Valls-Lafon A, Sánchez E, Jiménez R and Fortuny-Guasch C.

    The role of albuminuria in the follow-up of HIV-infected pediatric patients

    PEDIATRIC NEPHROLOGY . 29(9): 1561-1566. Nº de citas: 5

    [doi:10.1007/s00467-014-2814-7]

  • Madrid L, Noguera-Julián A, Falcon-Neyra L, Fortuny-Guasch C, De Felipe B, Torrebadell-Burriel M, Sanchez B, Valls-Lafon A, López-Cortès L, Benmarzouk-Hidalgo OJ and Neth O.

    Microbial translocation and T cell activation are not associated in chronic HIV-infected children

    Aids . 28(13): 1989-1992. Nº de citas: 5

    [doi:10.1097/QAD.0000000000000375]

  • Fortuny-Guasch C, Duiculescu D, Cheng K, Garges HP, Cotton M, Tamarirt DP, Ford SL, Wire MB, Givens N, Ross LL, Lou Y, Perger T and Sievers J.

    Pharmacokinetics and 48-week Safety and Antiviral Activity of Fosamprenavir-containing Regimens in HIV-infected 2-to 18-year-old Children

    PEDIATRIC INFECTIOUS DISEASE JOURNAL . 33(1): 50-56. Nº de citas: 6

    [doi:10.1097/INF.0b013e3182a1126a]